gliclazide - CISMeF

Preferred Label : gliclazide;

MeSH definition : An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.;

MeSH synonym : glyclazide; gliklazid;

CISMeF synonym : alphapharm brand of gliclazide; generics brand of gliclazide; genpharm brand of gliclazide; gliclazide servier brand; helsinn brand of gliclazide; novopharm brand of gliclazide; servier brand of gliclazide;

CISMeF acronym : S852;

DeCS synonym : S852;

MeSH hyponym : diabrezide; Gen-Gliclazide; diaikron; S-1702; diaglyk; glyade; Novo-Gliclazide; diamicron; S-852; S 1702; S1702; S 852; S852; Gen Gliclazide; Novo Gliclazide;

MeSH CAS label : benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-;

MeSH Related Number : 21187-98-4 (Gliclazide);

Registry Number MeSH : 21187-98-4;

Wikipedia link : https://en.wikipedia.org/wiki/Gliclazide;

Codes EINECS : 244-260-5;

Is substance : O;

UNII : G4PX8C4HKV;

InChIKey : BOVGTQGAOIONJV-BETUJISGSA-N;

Details

Origin ID

D005907;

UMLS CUI

C0017631;

ATC code(s)
- gliclazide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Gliclazide adverse reaction (disorder) [SNOMED CT concept]
- gliclazide [Substance BNPC]
Currated CISMeF NLP mapping
- Gliclazide [ICD-11 Extension code]
- Gliclazide [LOINC component]
- Gliclazide [ICHI extension code]
- Gliclazide [SMS substance]
- Gliclazide [NCIt concept]
- Gliclazide (substance) [SNOMED CT concept]
Pharmacological action(s)
- hypoglycemic agents [MeSH Descriptor]
Record concept(s)
- Gen-Gliclazide [MeSH concept]
- Novo-Gliclazide [MeSH concept]
- S-1702 [MeSH concept]
- S-852 [MeSH concept]
- diabrezide [MeSH concept]
- diaglyk [MeSH concept]
- diaikron [MeSH concept]
- diamicron [MeSH concept]
- gliclazide [MeSH concept]
- glyade [MeSH concept]
Related MeSH Supplementary Concept(s)
- hydroxygliclazide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Gliclazide [ICD-11 Extension code]
- Gliclazide [LOINC component]
- Gliclazide [NCIt concept]
- Gliclazide (substance) [SNOMED CT concept]
- Product containing gliclazide (medicinal product) [SNOMED CT concept]
- gliclazide [ATC Code]
- gliclazide [Substance BNPC]
Validated automatic mappings to BTNT
- gliclazide [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients